Adams Diversified Equity Fund, Inc. Enanta Pharmaceuticals Inc Transaction History

Adams Diversified Equity Fund, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$60.08 - $88.17 $60,080 - $88,170	-1,000 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$81.3 - $97.35 $105,690 - $126,554	-1,300 Reduced 56.52%	1,000 $84,000
Q1 2019 Apr 26, 2019	SELL	$69.08 - $105.66 $179,608 - $274,716	-2,600 Reduced 53.06%	2,300 $220,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $13,082 - $16,930	-200 Reduced 3.92%	4,900 $347,000
Q3 2018 Oct 29, 2018	SELL	$85.46 - $126.37 $25,637 - $37,911	-300 Reduced 5.56%	5,100 $436,000
Q2 2018 Jul 26, 2018	SELL	$81.85 - $120.51 $441,989 - $650,754	-5,400 Reduced 50.0%	5,400 $626,000
Q4 2017 Feb 13, 2018	SELL	$45.65 - $59.37 $419,980 - $546,204	-9,200 Reduced 46.0%	10,800 $634,000
Q3 2017 Oct 30, 2017	BUY	$37.91 - $46.8 $758,199 - $936,000	20,000	20,000 $936,000

110

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $115M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.